Global Candida Antarctica Lipase B Sales Analysis Report: By Region, Players, Type, Application 2026
On Jun 11, the latest report "Global Candida Antarctica Lipase B Market 2026 by Manufacturers, Regions, Types and Applications, Forecast to 2032" from Global Info Research provides a detailed and comprehensive analysis of the global Candida Antarctica Lipase B market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2026.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3657731/candida-antarctica-lipase-b
According to our (Global Info Research) latest study, the global Candida Antarctica Lipase B market size was valued at US$ 37.04 million in 2025 and is forecast to a readjusted size of US$ 64.05 million by 2032 with a CAGR of 8.1% during review period. Candida antarctica Lipase B (CALB) is a highly selective lipase originating from Candida antarctica (now often classified within Moesziomyces species). Commercial products are typically supplied as recombinant free liquid enzymes, powdered enzymes, or immobilized particulate biocatalysts. CALB is widely used for esterification, transesterification, hydrolysis, aminolysis, lactone ring-opening polymerization, and chiral resolution. The estimated overall gross margin is approximately 61%. CALB represents a relatively small but high-value segment within the specialty lipase market. While it accounts for only a small share of the global lipase market, its commercial value is concentrated in immobilized high-activity biocatalysts, chiral pharmaceutical intermediate synthesis, and premium lipid modification applications. Market growth is driven by three major trends. First, pharmaceutical API and intermediate manufacturers increasingly seek enzymatic routes to replace metal-catalyzed or strong acid/base processes, improving selectivity while reducing downstream purification burdens. Second, demand is rising for mild, low-byproduct processing in Omega-3 concentrates, structured lipids, human milk fat substitutes, and specialty functional oils. Third, advances in immobilization carriers, directed evolution, and expression host optimization have reduced enzyme consumption rates, allowing CALB to expand beyond laboratory-scale applications into commercial-scale biocatalytic production. Key constraints include relatively high catalyst cost, carrier leaching or activity loss during repeated use, and significant variation among substrate systems, which often necessitates laboratory and pilot-scale validation before commercial adoption. Over the medium term, CALB is expected to grow faster than conventional food-processing lipases, but its overall market size will remain substantially smaller than large-volume enzymes used in detergents, animal feed, and mainstream food processing. This report is a detailed and comprehensive analysis for global Candida Antarctica Lipase B market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Candida Antarctica Lipase B market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Free Liquid Formulation、Free Powder Preparation、Immobilized Granular Biocatalyst、Immobilized Microcarrier Biocatalyst、Whole-cell Biocatalyst
Market segment by Application: Pharmaceutical Intermediates and Chiral Resolution、Specialty Fats and Omega-3 Oils、Flavor, Fragrance and Cosmetic Esters、Bio-based Polyester Synthesis、Biodiesel and Oleochemical Processing、Research and Enzyme Engineering
Major players covered: Novonesis、Fermenta Biotech、Advanced Enzymes、KDN Biotech、SyncoZymes、Biosynth、Merck、Aladdin Scientific、Creative Enzymes、Creative BioMart、MedChemExpress、ProteoGenix
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Candida Antarctica Lipase B product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Candida Antarctica Lipase B, with price, sales quantity, revenue, and global market share of Candida Antarctica Lipase B from 2021 to 2026.
Chapter 3, the Candida Antarctica Lipase B competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Candida Antarctica Lipase B breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment Candida Antarctica Lipase B the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the Candida Antarctica Lipase B sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Candida Antarctica Lipase B market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Candida Antarctica Lipase B.
Chapter 14 and 15, to describe Candida Antarctica Lipase B sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Candida Antarctica Lipase B
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/3657731/candida-antarctica-lipase-b
According to our (Global Info Research) latest study, the global Candida Antarctica Lipase B market size was valued at US$ 37.04 million in 2025 and is forecast to a readjusted size of US$ 64.05 million by 2032 with a CAGR of 8.1% during review period. Candida antarctica Lipase B (CALB) is a highly selective lipase originating from Candida antarctica (now often classified within Moesziomyces species). Commercial products are typically supplied as recombinant free liquid enzymes, powdered enzymes, or immobilized particulate biocatalysts. CALB is widely used for esterification, transesterification, hydrolysis, aminolysis, lactone ring-opening polymerization, and chiral resolution. The estimated overall gross margin is approximately 61%. CALB represents a relatively small but high-value segment within the specialty lipase market. While it accounts for only a small share of the global lipase market, its commercial value is concentrated in immobilized high-activity biocatalysts, chiral pharmaceutical intermediate synthesis, and premium lipid modification applications. Market growth is driven by three major trends. First, pharmaceutical API and intermediate manufacturers increasingly seek enzymatic routes to replace metal-catalyzed or strong acid/base processes, improving selectivity while reducing downstream purification burdens. Second, demand is rising for mild, low-byproduct processing in Omega-3 concentrates, structured lipids, human milk fat substitutes, and specialty functional oils. Third, advances in immobilization carriers, directed evolution, and expression host optimization have reduced enzyme consumption rates, allowing CALB to expand beyond laboratory-scale applications into commercial-scale biocatalytic production. Key constraints include relatively high catalyst cost, carrier leaching or activity loss during repeated use, and significant variation among substrate systems, which often necessitates laboratory and pilot-scale validation before commercial adoption. Over the medium term, CALB is expected to grow faster than conventional food-processing lipases, but its overall market size will remain substantially smaller than large-volume enzymes used in detergents, animal feed, and mainstream food processing. This report is a detailed and comprehensive analysis for global Candida Antarctica Lipase B market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Candida Antarctica Lipase B market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Free Liquid Formulation、Free Powder Preparation、Immobilized Granular Biocatalyst、Immobilized Microcarrier Biocatalyst、Whole-cell Biocatalyst
Market segment by Application: Pharmaceutical Intermediates and Chiral Resolution、Specialty Fats and Omega-3 Oils、Flavor, Fragrance and Cosmetic Esters、Bio-based Polyester Synthesis、Biodiesel and Oleochemical Processing、Research and Enzyme Engineering
Major players covered: Novonesis、Fermenta Biotech、Advanced Enzymes、KDN Biotech、SyncoZymes、Biosynth、Merck、Aladdin Scientific、Creative Enzymes、Creative BioMart、MedChemExpress、ProteoGenix
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Candida Antarctica Lipase B product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Candida Antarctica Lipase B, with price, sales quantity, revenue, and global market share of Candida Antarctica Lipase B from 2021 to 2026.
Chapter 3, the Candida Antarctica Lipase B competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Candida Antarctica Lipase B breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment Candida Antarctica Lipase B the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the Candida Antarctica Lipase B sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2025.and Candida Antarctica Lipase B market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Candida Antarctica Lipase B.
Chapter 14 and 15, to describe Candida Antarctica Lipase B sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Candida Antarctica Lipase B
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
